Abbey Healthcare (Cromwell) Limited Company accounts

COMPANY REGISTRATION NUMBER: 07186527

Abbey Healthcare (Cromwell) Limited

Financial Statements

For the year ended

31 December 2025

Abbey Healthcare (Cromwell) Limited

Financial Statements

Year ended 31 December 2025

Contents	Page

Officers and professional advisers	1

Strategic report	2

Directors' report	3

Independent auditor's report to the members	5

Statement of income and retained earnings	9

Statement of financial position	10

Statement of cash flows	11

Notes to the financial statements	12

Abbey Healthcare (Cromwell) Limited

Officers and Professional Advisers

The board of directors	A Taylor
	M Cloonan
	B Raj (Appointed 1 June 2025)

Registered office	Abbey Healthcare
	Sutherland House
	70-78 West Hendon Broadway
	London
	NW9 7BT

Auditor	Streets Audit LLP
	Chartered accountants & statutory auditor
	Enterprise House
	38 Tyndall Court
	Commerce Road
	Lynch Wood
	Peterborough
	Cambridgeshire
	PE2 6LR

Abbey Healthcare (Cromwell) Limited

Strategic Report

Year ended 31 December 2025

The directors present the strategic report and the financial statements for the year ended 31 December 2025. Business review Abbey Healthcare (Cromwell) Limited operates a 66 bed care home regulated by the Care Quality Commission and was rated as 'requires improvement' during August 2023. Management is confident that this rating will be upgraded to a good rating with the next visit. Revenue has remained consistent in the year at £3.5m. This translated into a loss before tax of £489k (2024 - £315k). Principal risks and uncertainties Management monitors risks on a weekly and monthly basis. The primary concern of the management is the quality of care. There are dedicated regional managers and Operational Directors responsible for supporting the Home in provision of high quality care services. The major financial risk to the company is the increase in its cost base, primarily relating to the National Living Wage. The Company is exposed to credit risk with its customers, albeit major customers are public sector, and therefore with limited credit risk. Pricing risk is limited to the risk associated with negotiating annual price increases. Liquidity and cashflow risk could arise in the event of a downturn in trading. However, in this event, sister companies in the group can provide liquidity if required. The company is exposed to finance risk due to its exposure to third party lenders and borrowings in the Company. Staffing remains a key risk as there is a nationwide shortage of nurses and care staff. Cost inflation also remains a risk for the business. Financial and other key performance indicators The key financial and operational performance indicators monitored by management include regulatory reviews, internal quality reviews, occupancy ratios, average weekly fees and cost to revenue ratios. Future developments The directors continue to monitor its key performance metrics whilst continually striving to improve care quality.

This report was approved by the board of directors on 26 June 2026 and signed on behalf of the board by:

A Taylor

Director

Registered office:

Abbey Healthcare

Sutherland House

70-78 West Hendon Broadway

London

NW9 7BT

Abbey Healthcare (Cromwell) Limited

Directors' Report

Year ended 31 December 2025

The directors present their report and the financial statements of the company for the year ended 31 December 2025 .

Directors

The directors who served the company during the year were as follows:

A Taylor
M Cloonan
B Raj	(Appointed 1 June 2025)

Dividends

The directors do not recommend the payment of a dividend.

Disclosure of information in the strategic report

The company has chosen to include several items in the strategic report which would otherwise be required to be disclosed in the directors report. These include information on the exposure to financial risk, price risk, credit risk, liquidity risk and cash flow risk and an indication of the likely future developments in the business of the company.

Directors' responsibilities statement

The directors are responsible for preparing the strategic report, directors' report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: - select suitable accounting policies and then apply them consistently; - make judgments and accounting estimates that are reasonable and prudent; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Auditor

Each of the persons who is a director at the date of approval of this report confirms that:

- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

This report was approved by the board of directors on 26 June 2026 and signed on behalf of the board by:

A Taylor

Director

Registered office:

Abbey Healthcare

Sutherland House

70-78 West Hendon Broadway

London

NW9 7BT

Abbey Healthcare (Cromwell) Limited

Independent Auditor's Report to the Members of Abbey Healthcare (Cromwell) Limited

Year ended 31 December 2025

Opinion

We have audited the financial statements of Abbey Healthcare (Cromwell) Limited (the 'company') for the year ended 31 December 2025 which comprise the statement of income and retained earnings, statement of financial position, statement of cash flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its loss for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; - have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows: - the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations; - we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the company and sector in which it operates; - we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006 and taxation legislation, Care Home legislation and health and safety legislation; - we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and - identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit. We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by: - making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and - considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations. To address the risk of fraud through management bias and override of controls, we: - performed analytical procedures to identify any unusual or unexpected relationships; - tested journal entries to identify unusual transactions; - assessed whether judgements and assumptions made in determining the accounting estimates set out in Note 3 were indicative of potential bias; and - investigated the rationale behind significant or unusual transactions. In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to: - agreeing financial statement disclosures to underlying supporting documentation; - reading the minutes of meetings of those charged with governance; - inquiring of management as to actual and potential litigation and claims; and - reviewing correspondence with HMRC, relevant regulators and the company's legal advisors. There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to inquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. Use of our report

This report is made solely to the company's members, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Jonathan Day

(Senior Statutory Auditor)

For and on behalf of

Streets Audit LLP

Chartered accountants & statutory auditor

Enterprise House

38 Tyndall Court

Commerce Road

Lynch Wood

Peterborough

Cambridgeshire

PE2 6LR

27 June 2026

Abbey Healthcare (Cromwell) Limited

Statement of Income and Retained Earnings

Year ended 31 December 2025

		2025	2024
Note		£	£
Turnover	4	3,506,948	3,498,593

Cost of sales	2,646,840	2,441,683
	------------	------------
Gross profit	860,108	1,056,910

Administrative expenses		1,337,717	1,341,702
		------------	------------
Operating loss	5	( 477,609)	( 284,792)

Interest payable and similar expenses	9	11,420	29,766
		------------	------------
Loss before taxation		( 489,029)	( 314,558)

Tax on loss	10	( 13,517)	99,154
		---------	---------
Loss for the financial year and total comprehensive income		( 475,512)	( 413,712)
		---------	---------

Retained earnings at the start of the year	192,744	606,456
	---------	---------
Retained (losses)/earnings at the end of the year	( 282,768)	192,744
	---------	---------

All the activities of the company are from continuing operations.

Abbey Healthcare (Cromwell) Limited

Statement of Financial Position

31 December 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	11	534,952	526,600

Current assets

Debtors	12	5,910,137	5,791,627
Cash at bank and in hand		390,855	41,393
		------------	------------
		6,300,992	5,833,020

Creditors: amounts falling due within one year	13	6,959,538	5,984,901
		------------	------------
Net current liabilities		658,546	151,881
		---------	---------
Total assets less current liabilities		( 123,594)	374,719

Creditors: amounts falling due after more than one year	14	72,537	81,821

Provisions	16	85,637	99,154
		---------	---------
Net (liabilities)/assets		( 281,768)	193,744
		---------	---------

Capital and reserves

Called up share capital	18	1,000	1,000
Profit and loss account	19	( 282,768)	192,744
		---------	---------
Shareholders (deficit)/funds		( 281,768)	193,744
		---------	---------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the medium companies regime.

These financial statements were approved by the board of directors and authorised for issue on 26 June 2026 , and are signed on behalf of the board by:

A Taylor

Director

Company registration number: 07186527

Abbey Healthcare (Cromwell) Limited

Statement of Cash Flows

Year ended 31 December 2025

	2025	2024
	£	£

Cash flows from operating activities

Loss for the financial year	( 475,512)	( 413,712)

Adjustments for:
Depreciation of tangible assets	205,759	187,281
Interest payable and similar expenses	11,420	29,766
Tax on loss	( 13,517)	99,154
Accrued expenses	4,486	28,861

Changes in:
Trade and other debtors	( 118,510)	( 154,818)
Trade and other creditors	( 282,532)	175,137
	---------	---------
Cash generated from operations	( 668,406)	( 48,331)

Interest paid	( 11,420)	( 29,766)
	---------	--------
Net cash used in operating activities	( 679,826)	( 78,097)
	---------	--------

Cash flows from investing activities

Purchase of tangible assets	( 214,111)	( 124,715)
	---------	---------
Net cash used in investing activities	( 214,111)	( 124,715)
	---------	---------

Cash flows from financing activities

Proceeds from loans from group undertakings	1,250,295	( 151,819)
Payments of finance lease liabilities	( 6,896)	( 19,403)
	------------	---------
Net cash from/(used in) financing activities	1,243,399	( 171,222)
	------------	---------

Net increase/(decrease) in cash and cash equivalents	349,462	( 374,034)
Cash and cash equivalents at beginning of year	41,393	415,427
	---------	---------
Cash and cash equivalents at end of year	390,855	41,393
	---------	---------

Abbey Healthcare (Cromwell) Limited

Notes to the Financial Statements

Year ended 31 December 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Abbey Healthcare, Sutherland House, 70-78 West Hendon Broadway, London, NW9 7BT.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The directors have prepared the financial statements on a going concern basis. The company and group has sufficient resources to meet liabilities as they fall due for payment for a period of at lease 12 months from the date the financial statements are approved.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In preparing these financial statements, the directors have made the following judgements:- 1 Determine whether there are indicators of impairment of the tangible and intangible assets, including goodwill. Factors taken into consideration in reaching such a decision include the economic viability and expected future financial performance of the asset and where it is a component of a larger cash-generating unit, the viability and expected future performance of that unit. Other key sources of estimation uncertainty 2 Tangible fixed assets Tangible fixed assets, other than investment properties, are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number of factors. In re-assessing asset lives, factors such as technological innovation, product life cycles and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all material timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Fixtures and fittings	-	20% straight line

Finance leases and hire purchase contracts

Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

Financial instruments

The company holds basic financial instruments as defined in FRS102. The financial assets and financial liabilities of the company and their measurement basis are as follows: Financial assets - trade and other debtors are basic financial instruments and are debt instruments measured at amortised cost. Prepayments are not financial instruments. Cash at bank is classified as a basic financial instrument and is measured at amortised cost. Financial liabilities - trade creditors, accruals and other creditors are financial instruments, and are measured at amortised cost. Taxation and social security are not included in the financial instruments disclosure definition.

4. Turnover

Turnover arises from:

	2025	2024
	£	£
Rendering of services	3,506,948	3,498,593
	------------	------------

The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.

5. Operating loss

Operating profit or loss is stated after charging:

	2025	2024
	£	£
Depreciation of tangible assets	205,759	187,281
Rent paid	550,000	550,000
	---------	---------

6. Auditor's remuneration

	2025	2024
	£	£
Fees payable for the audit of the financial statements	4,800	4,800
	-------	-------

7. Staff costs

The average number of persons employed by the company during the year, including the directors, amounted to:

	2025	2024
	No.	No.
Production staff	73	72
	----	----

The aggregate payroll costs incurred during the year, relating to the above, were:

	2025	2024
	£	£
Wages and salaries	2,180,881	2,023,849
Social security costs	241,802	184,536
	------------	------------
	2,422,683	2,208,385
	------------	------------

8. Directors' remuneration

The directors' aggregate remuneration in respect of qualifying services was:

	2025	2024
	£	£
Remuneration	18,467	16,375
	--------	--------

9. Interest payable and similar expenses

	2025	2024
	£	£
Interest on obligations under finance leases and hire purchase contracts	14,574	17,023
Interest due to group undertakings	( 3,418)	12,743
Other interest payable and similar charges	264	–
	--------	--------
	11,420	29,766
	--------	--------

10. Tax on loss

Major components of tax (income)/expense

	2025	2024
	£	£

Deferred tax:

Origination and reversal of timing differences	( 13,517)	99,154
	--------	--------
Tax on loss	( 13,517)	99,154
	--------	--------

Reconciliation of tax (income)/expense

The tax assessed on the loss on ordinary activities for the year is higher than (2024: higher than) the standard rate of corporation tax in the UK of 25 % (2024: 25 %).

	2025	2024
	£	£
Loss on ordinary activities before taxation	( 489,029)	( 314,558)
	---------	---------
Loss on ordinary activities by rate of tax	( 122,257)	( 78,640)
Effect of expenses not deductible for tax purposes	17,847	–
Effect of capital allowances and depreciation	( 13,517)	99,154
Utilisation of tax losses	104,410	78,640
	---------	---------
Tax on loss	( 13,517)	99,154
	---------	---------

11. Tangible assets

	Fixtures and fittings
	£
Cost
At 1 January 2025	1,001,727
Additions	214,111
Disposals	( 27,951)
	------------
At 31 December 2025	1,187,887
	------------
Depreciation
At 1 January 2025	475,127
Charge for the year	205,759
Disposals	( 27,951)
	------------
At 31 December 2025	652,935
	------------
Carrying amount
At 31 December 2025	534,952
	------------
At 31 December 2024	526,600
	------------

12. Debtors

	2025	2024
	£	£
Trade debtors	271,398	177,918
Amounts owed by group undertakings	4,770,699	4,609,047
Prepayments and accrued income	67,356	54,082
Other debtors	800,684	950,580
	------------	------------
	5,910,137	5,791,627
	------------	------------

13. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	248,844	297,060
Amounts owed to group undertakings	6,442,882	5,192,587
Accruals and deferred income	202,470	197,984
Social security and other taxes	45,129	281,575
Obligations under finance leases and hire purchase contracts	17,812	15,424
Other creditors	2,401	271
	------------	------------
	6,959,538	5,984,901
	------------	------------

Hire purchase agreements are secured against the assets to which they relate.

14. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Obligations under finance leases and hire purchase contracts	72,537	81,821
	--------	--------

Hire purchase agreements are secured against the assets to which they relate.

15. Finance leases and hire purchase contracts

The total future minimum lease payments under finance leases and hire purchase contracts are as follows:

	2025	2024
	£	£
Not later than 1 year	17,812	15,424
Later than 1 year and not later than 5 years	72,537	81,821
	--------	--------
	90,349	97,245
	--------	--------

16. Provisions

	Deferred tax (note 17)
	£
At 1 January 2025	99,154
Additions	( 13,517)
	--------
At 31 December 2025	85,637
	--------

17. Deferred tax

The deferred tax included in the statement of financial position is as follows:

	2025	2024
	£	£
Included in provisions (note 16)	85,637	99,154
	--------	--------

The deferred tax account consists of the tax effect of timing differences in respect of:

	2025	2024
	£	£
Accelerated capital allowances	85,637	99,154
	--------	--------

18. Called up share capital

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	1,000	1,000	1,000	1,000
	-------	-------	-------	-------

19. Reserves

Profit and loss account - This reserve records retained earnings and accumulated losses.

20. Analysis of changes in net debt

	At 1 Jan 2025	Cash flows	Other changes	At 31 Dec 2025
	£	£	£	£
Cash at bank and in hand	41,393	349,462	–	390,855
Debt due within one year	(5,208,011)	(1,234,871)	(17,812)	(6,460,694)
Debt due after one year	(81,821)	81,821	(72,537)	(72,537)
	------------	------------	--------	------------
	( 5,248,439)	( 803,588)	( 90,349)	( 6,142,376)
	------------	------------	--------	------------

Abbey Healthcare (Cromwell) Limited

Notes to the Financial Statements (continued)

Year ended 31 December 2025

21. Operating leases

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£
Not later than 1 year	–	91,667
	----	--------

22. Contingencies

The company has provided a cross guarantee for loans in a related company.

23. Related party transactions

The company paid key management remuneration totalling £18,467 (2024 - £16,375). The company has taken exemption under FRS102 from disclosing transactions with wholly owned members of the same group.

24. Controlling party

The company was under the control of the Trustees of the Prabhdyal Sodhi Overseas Settlement throughout the year, an entity based in Gibraltar. The immediate parent company is Lansbury Limited, a company incorporated in Gibraltar.